Plain-English translation of NCT07399002 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This trial is testing the Ultimaster Nagomi™ stent, a special tube device placed inside narrowed heart arteries to keep blood flowing properly. The study focuses on treating longer blockages using a single stent rather than multiple ones. Researchers want to confirm that this treatment works well and is safe for patients in everyday medical practice.
The manufacturer needs to gather real-world information about how this medication performs after it's been approved and is being used in hospitals. This helps confirm that the treatment continues to work as expected and remains safe for patients like you.
You likely qualify if…
You likely don't qualify if…
You would come to the hospital to receive the stent procedure, which involves placing the device into your blocked artery to restore blood flow. After the procedure, you would have follow-up visits with your doctor to monitor how well the stent is working and check for any side effects. The study gathers information about your health and recovery over time as part of standard post-market safety monitoring.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Spain